CCZ1B_HUMAN - dbPTM
CCZ1B_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CCZ1B_HUMAN
UniProt AC P86790
Protein Name Vacuolar fusion protein CCZ1 homolog B
Gene Name CCZ1B
Organism Homo sapiens (Human).
Sequence Length 482
Subcellular Localization Lysosome membrane .
Protein Description
Protein Sequence MAAAAAGAGSGPWAAQEKQFPPALLSFFIYNPRFGPREGQEENKILFYHPNEVEKNEKIRNVGLCEAIVQFTRTFSPSKPAKSLHTQKNRQFFNEPEENFWMVMVVRNPIIEKQSKDGKPVIEYQEEELLDKVYSSVLRQCYSMYKLFNGTFLKAMEDGGVKLLKERLEKFFHRYLQTLHLQSCDLLDIFGGISFFPLDKMTYLKIQSFINRMEESLNIVKYTAFLYNDQLIWSGLEQDDMRILYKYLTTSLFPRHIEPELAGRDSPIRAEMPGNLQHYGRFLTGPLNLNDPDAKCRFPKIFVNTDDTYEELHLIVYKAMSAAVCFMIDASVHPTLDFCRRLDSIVGPQLTVLASDICEQFNINKRMSGSEKEPQFKFIYFNHMNLAEKSTVHMRKTPSVSLTSVHPDLMKILGDINSDFTRVDEDEEIIVKAMSDYWVVGKKSDRRELYVILNQKNANLIEVNEEVKKLCATQFNNIFFLD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAAAAAGAG
------CCCCCCCCC
13.0522223895
10PhosphorylationAAAAGAGSGPWAAQE
CCCCCCCCCHHHHHH
40.9425159151
44UbiquitinationREGQEENKILFYHPN
CCCCCCCCEEEECCC
44.03-
45UbiquitinationEGQEENKILFYHPNE
CCCCCCCEEEECCCH
4.9221890473
55UbiquitinationYHPNEVEKNEKIRNV
ECCCHHHCCHHHCCC
75.48-
74PhosphorylationAIVQFTRTFSPSKPA
HHHHHHHCCCCCCCC
25.9623927012
76PhosphorylationVQFTRTFSPSKPAKS
HHHHHCCCCCCCCCC
27.8723927012
78PhosphorylationFTRTFSPSKPAKSLH
HHHCCCCCCCCCCCC
50.5028985074
79UbiquitinationTRTFSPSKPAKSLHT
HHCCCCCCCCCCCCC
52.99-
82UbiquitinationFSPSKPAKSLHTQKN
CCCCCCCCCCCCHHC
63.18-
88UbiquitinationAKSLHTQKNRQFFNE
CCCCCCHHCHHHCCC
56.08-
89UbiquitinationKSLHTQKNRQFFNEP
CCCCCHHCHHHCCCC
32.9221890473
113UbiquitinationVRNPIIEKQSKDGKP
EECHHHCCCCCCCCC
49.84-
116UbiquitinationPIIEKQSKDGKPVIE
HHHCCCCCCCCCCEE
68.92-
117UbiquitinationIIEKQSKDGKPVIEY
HHCCCCCCCCCCEEE
75.4921890473
119UbiquitinationEKQSKDGKPVIEYQE
CCCCCCCCCCEEECH
46.36-
120UbiquitinationKQSKDGKPVIEYQEE
CCCCCCCCCEEECHH
37.5421890473
124PhosphorylationDGKPVIEYQEEELLD
CCCCCEEECHHHHHH
15.3129496907
132UbiquitinationQEEELLDKVYSSVLR
CHHHHHHHHHHHHHH
42.94-
134PhosphorylationEELLDKVYSSVLRQC
HHHHHHHHHHHHHHH
10.8529496907
136PhosphorylationLLDKVYSSVLRQCYS
HHHHHHHHHHHHHHH
13.90-
142PhosphorylationSSVLRQCYSMYKLFN
HHHHHHHHHHHHHHC
6.53-
143PhosphorylationSVLRQCYSMYKLFNG
HHHHHHHHHHHHHCC
24.22-
145PhosphorylationLRQCYSMYKLFNGTF
HHHHHHHHHHHCCCH
9.90-
162UbiquitinationAMEDGGVKLLKERLE
HHHHCCHHHHHHHHH
51.91-
170AcetylationLLKERLEKFFHRYLQ
HHHHHHHHHHHHHHH
58.9019608861
216PhosphorylationFINRMEESLNIVKYT
HHHHHHHHHCHHHHH
17.26-
246UbiquitinationDDMRILYKYLTTSLF
HHHHHHHHHHHHHCC
30.27-
247PhosphorylationDMRILYKYLTTSLFP
HHHHHHHHHHHHCCC
8.8424114839
247UbiquitinationDMRILYKYLTTSLFP
HHHHHHHHHHHHCCC
8.8421890473
266PhosphorylationPELAGRDSPIRAEMP
HHHCCCCCCCCCCCC
22.3629255136
266PhosphorylationPELAGRDSPIRAEMP
HHHCCCCCCCCCCCC
22.3618669648
279PhosphorylationMPGNLQHYGRFLTGP
CCCCHHCCCCCCCCC
9.3129978859
295AcetylationNLNDPDAKCRFPKIF
CCCCCCCCCCCCEEE
33.0725953088
295UbiquitinationNLNDPDAKCRFPKIF
CCCCCCCCCCCCEEE
33.07-
368PhosphorylationFNINKRMSGSEKEPQ
CCCCCCCCCCCCCCC
43.1126657352
370PhosphorylationINKRMSGSEKEPQFK
CCCCCCCCCCCCCCE
37.8820068231
372AcetylationKRMSGSEKEPQFKFI
CCCCCCCCCCCCEEE
76.1225953088
372UbiquitinationKRMSGSEKEPQFKFI
CCCCCCCCCCCCEEE
76.12-
373UbiquitinationRMSGSEKEPQFKFIY
CCCCCCCCCCCEEEE
40.0421890473
380PhosphorylationEPQFKFIYFNHMNLA
CCCCEEEEEECCCHH
11.0628152594
389UbiquitinationNHMNLAEKSTVHMRK
ECCCHHHHCCEECCC
45.91-
396UbiquitinationKSTVHMRKTPSVSLT
HCCEECCCCCCCEEE
58.16-
397PhosphorylationSTVHMRKTPSVSLTS
CCEECCCCCCCEEEE
15.4929978859
399PhosphorylationVHMRKTPSVSLTSVH
EECCCCCCCEEEECC
29.5729978859
401PhosphorylationMRKTPSVSLTSVHPD
CCCCCCCEEEECCHH
30.2123186163
403PhosphorylationKTPSVSLTSVHPDLM
CCCCCEEEECCHHHH
22.6123186163
404PhosphorylationTPSVSLTSVHPDLMK
CCCCEEEECCHHHHH
24.5823186163
411UbiquitinationSVHPDLMKILGDINS
ECCHHHHHHHCCCCC
41.92-
435PhosphorylationEIIVKAMSDYWVVGK
HHHHHHHCCEEEEEE
32.2028796482
437PhosphorylationIVKAMSDYWVVGKKS
HHHHHCCEEEEEECC
7.8728796482
442UbiquitinationSDYWVVGKKSDRREL
CCEEEEEECCCCCEE
37.18-
443UbiquitinationDYWVVGKKSDRRELY
CEEEEEECCCCCEEE
52.22-
450PhosphorylationKSDRRELYVILNQKN
CCCCCEEEEEEECCC
4.8227642862
456UbiquitinationLYVILNQKNANLIEV
EEEEEECCCCCEEEC
57.88-
468UbiquitinationIEVNEEVKKLCATQF
EECCHHHHHHHHHHC
43.22-
469UbiquitinationEVNEEVKKLCATQFN
ECCHHHHHHHHHHCC
54.71-
469UbiquitinationEVNEEVKKLCATQFN
ECCHHHHHHHHHHCC
54.7121890473

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CCZ1B_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CCZ1B_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CCZ1B_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of CCZ1B_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CCZ1B_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-170, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-266, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-266, AND MASSSPECTROMETRY.

TOP